MATV Stock Analysis: Mativ Holdings | NYSE

Specialty Chemicals | NYSE, USA | Market Cap: 662m USD | 12M Return: 7.9% | US8085411069 | Charts, Fundamentals & Technical Analysis

Specialty Papers, Adhesive Tapes, Filtration Media, Advanced Films
Total Rating 55
Safety 75
Buy Signal 1.36
Specialty Chemicals
Industry Rotation: +1.7
Market Cap: 662M
Avg Turnover: 6.04M
Risk 3d forecast
Volatility64.3%
VaR 5th Pctl9.38%
VaR vs Median-8.47%
Reward TTM
Sharpe Ratio0.33
Rel. Str. IBD74.4
Rel. Str. Peer Group86.4
Character TTM
Beta2.006
Beta Downside2.015
Hurst Exponent0.517
Drawdowns 3y
Max DD75.27%
CAGR/Max DD-0.07
CAGR/Mean DD-0.15
EPS (Earnings per Share) EPS (Earnings per Share) of MATV over the last years for every Quarter: "2021-06": 0.9, "2021-09": 0.82, "2021-12": 0.08, "2022-03": 0.89, "2022-06": 0.36, "2022-09": 0.74, "2022-12": 0.56, "2023-03": 0.25, "2023-06": 0.51, "2023-09": 0.21, "2023-12": 0.23, "2024-03": 0.02, "2024-06": 0.34, "2024-09": 0.21, "2024-12": 0.05, "2025-03": -0.14, "2025-06": 0.33, "2025-09": 0.39, "2025-12": 0.15, "2026-03": 0.06, "2026-06": 0.5,
EPS CAGR: -14.42%
EPS Trend: -37.8%
Last SUE: 3.16
Qual. Beats: 1
Revenue Revenue of MATV over the last years for every Quarter: 2021-06: 377.8, 2021-09: 383.6, 2021-12: 390.4, 2022-03: 406.8, 2022-06: 426.4, 2022-09: 551.5, 2022-12: 660.1, 2023-03: 549, 2023-06: 526.5, 2023-09: 498.2, 2023-12: 452.3, 2024-03: 500.2, 2024-06: 523.799999, 2024-09: 498.5, 2024-12: 458.6, 2025-03: 484.8, 2025-06: 525.4, 2025-09: 513.7, 2025-12: 463.1, 2026-03: 479.6, 2026-06: 531.8,
Rev. CAGR: -2.00%
Rev. Trend: -51.5%
Last SUE: 1.53
Qual. Beats: 1

Warnings

Earnings Expected To Drop (P/E To P/E Forward)
High Debt/EBITDA With Thin Interest Coverage
Interest Coverage Ratio Critical

Tailwinds

Supp Ema8
Idiosyncratic Leader

Seasonality 11.6 years of data

Jan -1.2% 5
Feb -3.8% 5
Mar -0.1% 7
Apr -1.5% 20
May -0.7% 17
Jun -0.8% 8
Jul +5.2% 23
Aug +1.7% 18
Sep -4.3% 34
Oct +0.9% 2
Nov +0.5% 0
Dec +2.7% 17

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: MATV Mativ Holdings

Mativ Holdings, Inc. is a U.S.-based specialty materials manufacturer that operates across two reportable segments: Filtration & Advanced Materials and Sustainable & Adhesive Solutions. The companys products, which include engineered polymer and fiber-based substrates, nonwovens, films, adhesive tapes, tapes, labels, liners, and specialty papers, serve a broad range of end-markets such as transportation, water and air filtration, construction, healthcare, industrial, personal care, and consumer goods. The company sells its products in the United States, Europe, the Asia Pacific, the Americas, and other international markets.

The business operates within the GICS Materials sector (Paper Products sub-industry) and follows a B2B model, supplying components and substrates to other manufacturers rather than selling finished consumer goods directly. Its diversified portfolio spans both industrial applications, such as filtration media, protective substrates, and performance labels, and consumer-adjacent end uses, including wound care, stationery, craft papers, and wallpaper.

Mativ Holdings was incorporated in 1995 and is headquartered in Alpharetta, Georgia. The company was formerly known as Schweitzer-Mauduit International, Inc., adopting its current name in July 2022 following the combination of SWM and Neenah, which expanded its paper and packaging footprint alongside its legacy specialty materials operations.

Headlines to Watch Out For
  • Filtration segment margins compressed by raw material inflation
  • Construction and infrastructure demand boosts adhesive tapes revenue
  • Neenah integration synergies support debt reduction and margin expansion
Piotroski VR-10 (Strict) 5.5
Net Income: 89.5m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.19 > 1.0
NWC/Revenue: 16.29% < 20% (prev 20.63%; Δ -4.34% < -1%)
CFO/TA 0.08 > 3% & CFO 161.0m > Net Income 89.5m
Net Debt (1.03b) to EBITDA (123.7m): 8.32 < 3
Current Ratio: 1.98 > 1.5 & < 3
Outstanding Shares: last quarter (55.7m) vs 12m ago 1.93% < -2%
Gross Margin: 17.75% > 18% (prev 17.66%; Δ 0.09% > 0.5%)
Asset Turnover: 97.76% > 50% (prev 94.73%; Δ 3.03% > 0%)
Interest Coverage Ratio: 0.75 > 6 (EBIT TTM 53.8m / Interest Expense TTM 71.5m)
Altman Z'' 1.22
A: 0.16 (Total Current Assets 655.2m - Total Current Liabilities 331.3m) / Total Assets 1.99b
B: -0.11 (Retained Earnings -215.1m / Total Assets 1.99b)
C: 0.03 (EBIT TTM 53.8m / Avg Total Assets 2.03b)
D: 0.31 (Book Value of Equity 470.7m / Total Liabilities 1.52b)
Altman-Z'' = 1.22 = BB
Beneish M -3.00
DSRI: 0.97 (Receivables 221.8m/225.5m, Revenue 1.99b/1.97b)
GMI: 1.00 (GM 17.66% / 17.75%)
AQI: 1.07 (AQ_t 0.35 / AQ_t-1 0.32)
SGI: 1.01 (Revenue 1.99b / 1.97b)
TATA: -0.04 (NI 89.5m - CFO 161.0m) / TA 1.99b)
Beneish M = -3.00 (Cap -4..+1) = AA
What is the price of MATV shares?

As of August 23, 2026, the stock is trading at USD 12.47 with a total of 352,799 shares traded. Over the past week, the price has changed by +2.13%, over one month by +54.33%, over three months by +47.11% and over the past year by +7.94%.

Current recommended Stop Loss: 11.40 (which is 8.6% or 1.8 ATR below the current price).

Is MATV a buy, sell or hold?

Mativ Holdings has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy MATV.

  • StrongBuy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the MATV price?
Analysts Target Price 21 68.4%
Mativ Holdings (MATV) - Fundamental Data Overview as of 22 August 2026
Market Cap USD = 662.3m (662.3m USD * 1.0 USD.USD)
P/E Trailing = 7.4074
P/E Forward = 17.1233
P/S = 0.3331
P/B = 1.4246
P/EG = 1.8363
Revenue TTM = 1.99b USD
EBIT TTM = 53.8m USD
EBITDA TTM = 123.7m USD
Long Term Debt = 970.1m USD (from longTermDebt, last quarter)
Short Term Debt = 13.4m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 60.4m
Net Debt = 1.03b USD (calculated: Debt 1.10b - CCE 66.3m)
Enterprise Value = 1.69b USD (662.3m + Debt 1.10b - CCE 66.3m)
Interest Coverage Ratio = 0.75 (Ebit TTM 53.8m / Interest Expense TTM 71.5m)
EV/FCF = 13.24x (Enterprise Value 1.69b / FCF TTM 127.7m)
FCF Yield = 7.55% (FCF TTM 127.7m / Enterprise Value 1.69b)
FCF Margin = 6.42% (FCF TTM 127.7m / Revenue TTM 1.99b)
Net Margin = 4.50% (Net Income TTM 89.5m / Revenue TTM 1.99b)
Gross Margin = 17.75% ((Revenue TTM 1.99b - Cost of Revenue TTM 1.64b) / Revenue TTM)
Gross Margin QoQ = 21.31% (prev 14.37%)
Tobins Q-Ratio = 0.85 (Enterprise Value 1.69b / Total Assets 1.99b)
Interest Expense / Debt = 6.53% (Interest Expense 71.5m / Debt 1.10b)
Taxrate = 47.06% (3.20m / 6.80m)
NOPAT = 28.5m (EBIT 53.8m * (1 - 47.06%))
Current Ratio = 1.98 (Total Current Assets 655.2m / Total Current Liabilities 331.3m)
Debt / Equity = 2.33 (Debt 1.10b / totalStockholderEquity, last quarter 470.7m)
Debt / EBITDA = 8.32 (Net Debt 1.03b / EBITDA 123.7m)
Debt / FCF = 8.06 (Net Debt 1.03b / FCF TTM 127.7m)
Total Stockholder Equity = 459.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.40% (Net Income 89.5m / Total Assets 1.99b)
RoE = 19.47% (Net Income TTM 89.5m / Total Stockholder Equity 459.8m)
RoCE = 3.76% (EBIT 53.8m / Capital Employed (Equity 459.8m + L.T.Debt 970.1m))
RoIC = 1.77% (NOPAT 28.5m / Invested Capital 1.61b)
WACC = 7.07% (E(662.3m)/V(1.76b) * Re(13.04%) + D(1.10b)/V(1.76b) * Rd(6.53%) * (1-Tc(0.47)))
Discount Rate = 13.04% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 81.21 | Cagr: 1.15%
[DCF] Terminal Value 77.97% ; FCFF base≈95.1m ; Y1≈109.0m ; Y5≈160.4m
[DCF] Fair Price = 25.08 (EV 2.41b - Net Debt 1.03b = Equity 1.38b / Shares 55.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -37.83 | EPS CAGR: -14.42% | SUE: 3.16 | # QB: 1
Revenue Correlation: -51.53 | Revenue CAGR: -2.00% | SUE: 1.53 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.25 | Chg30d=-26.47% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=0.97 | Chg30d=+14.12% | Revisions=-40% | GrowthEPS=+38.6% | GrowthRev=+1.8%
EPS next Year (2027-12-31): EPS=1.25 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+28.9% | GrowthRev=+3.3%